Moreover, apart from the presence or absence of NAFLD, liraglutide reduced liver fat content as assessed by MRI spectroscopy in patients with uncontrolled T2DM thanks to its weight-lowering effect, whereas insulin glargine, despite its effective control of glycemic status, produced no improvement in weight loss and liver fat content [74]
Pen sharing poses a risk for transmission of blood-borne pathogens
interessante notare che, in unanalisi sistematica, luso di metformina di base stato associato a una maggiore incidenza di nausea e vomito in caso di utilizzo di un GLP-1RA
Underlying medical conditions: Certain conditions can blunt weight loss responses, including hypothyroidism (a thyroid function test is advisable if not recently checked), Cushing's syndrome or exogenous corticosteroid use, polycystic ovary syndrome (PCOS), and obstructive sleep apnoea (OSA)